Splenic marginal zone lymphomas (MZL) express mutated (M)) or unmutated (U)) immunoglobulin heavy chain (IGHV) genes. To investigate the IGHV mutational status impact on genetic lesions, this study combined single nucleotide polymorphism-arrays and IGHV sequencing in 83 cases. Clinical features and outcome were similar between U- and M-IGHV cases. Recurrent lesions frequency was higher in U-IGHV cases, including poor prognosticators. Frequencies differed among cases bearing individual IGHV genes or lambda light chains. In conclusion, SMZL comprises subgroups based on genetic abnormalities and immunogenetic status. Genomic lesion frequency differed and was higher in U-IGHV cases, possibly affecting the outcome.

Immunogenetics features and genomic lesions in splenic marginal zone lymphoma / Rinaldi, A; Forconi, F; Arcaini, L; Mian, M; Sozzi, E; Zibellini, S; Baldini, L; Franceschetti, S; Gaidano, G; Marasca, Roberto; Mollejo, M; Piris, Ma; Tucci, A; Facchetti, F; Bhagat, G; Favera, Rd; Rancoita, Pm; Zucca, E; Kwee, I; Bertoni, F.. - In: BRITISH JOURNAL OF HAEMATOLOGY. - ISSN 0007-1048. - STAMPA. - 151:5(2010), pp. 435-439. [10.1111/j.1365-2141.2010.08347.x]

Immunogenetics features and genomic lesions in splenic marginal zone lymphoma

MARASCA, Roberto;
2010

Abstract

Splenic marginal zone lymphomas (MZL) express mutated (M)) or unmutated (U)) immunoglobulin heavy chain (IGHV) genes. To investigate the IGHV mutational status impact on genetic lesions, this study combined single nucleotide polymorphism-arrays and IGHV sequencing in 83 cases. Clinical features and outcome were similar between U- and M-IGHV cases. Recurrent lesions frequency was higher in U-IGHV cases, including poor prognosticators. Frequencies differed among cases bearing individual IGHV genes or lambda light chains. In conclusion, SMZL comprises subgroups based on genetic abnormalities and immunogenetic status. Genomic lesion frequency differed and was higher in U-IGHV cases, possibly affecting the outcome.
2010
151
5
435
439
Immunogenetics features and genomic lesions in splenic marginal zone lymphoma / Rinaldi, A; Forconi, F; Arcaini, L; Mian, M; Sozzi, E; Zibellini, S; Baldini, L; Franceschetti, S; Gaidano, G; Marasca, Roberto; Mollejo, M; Piris, Ma; Tucci, A; Facchetti, F; Bhagat, G; Favera, Rd; Rancoita, Pm; Zucca, E; Kwee, I; Bertoni, F.. - In: BRITISH JOURNAL OF HAEMATOLOGY. - ISSN 0007-1048. - STAMPA. - 151:5(2010), pp. 435-439. [10.1111/j.1365-2141.2010.08347.x]
Rinaldi, A; Forconi, F; Arcaini, L; Mian, M; Sozzi, E; Zibellini, S; Baldini, L; Franceschetti, S; Gaidano, G; Marasca, Roberto; Mollejo, M; Piris, Ma...espandi
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/695059
Citazioni
  • ???jsp.display-item.citation.pmc??? 4
  • Scopus 19
  • ???jsp.display-item.citation.isi??? 14
social impact